Extended Zerlasiran Data Show Sustained Lp(a) Reduction ...Middle East

The experimental siRNA agent led to prolonged Lp(a) reduction of more than 90%, extended data from the phase 1 trial show, supporting the move to phases 2 and 3 trials. Medscape Medical News

Hence then, the article about extended zerlasiran data show sustained lp a reduction was published today ( Friday 12/04/2024 - 08:37 AM ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Extended Zerlasiran Data Show Sustained Lp(a) Reduction )

Also on site :

• US cable outlines new ‘construct’ to control Strait of Hormuz – media
• ’80s Thrash Metal Frontman, Who Survived Rare Cancer, Announces New Project
• Press freedom worldwide falls to its lowest level in 25 years